CA2695526A1 - High speed swelling, pressure exerting hemostatic device - Google Patents
High speed swelling, pressure exerting hemostatic device Download PDFInfo
- Publication number
- CA2695526A1 CA2695526A1 CA2695526A CA2695526A CA2695526A1 CA 2695526 A1 CA2695526 A1 CA 2695526A1 CA 2695526 A CA2695526 A CA 2695526A CA 2695526 A CA2695526 A CA 2695526A CA 2695526 A1 CA2695526 A1 CA 2695526A1
- Authority
- CA
- Canada
- Prior art keywords
- polymer particles
- hemostatic
- porous membrane
- membrane
- fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002439 hemostatic effect Effects 0.000 title claims description 125
- 230000008961 swelling Effects 0.000 title description 55
- 229920000642 polymer Polymers 0.000 claims description 122
- 239000002245 particle Substances 0.000 claims description 106
- 239000012528 membrane Substances 0.000 claims description 94
- 210000004369 blood Anatomy 0.000 claims description 82
- 239000012530 fluid Substances 0.000 claims description 82
- 239000008280 blood Substances 0.000 claims description 81
- 239000000463 material Substances 0.000 claims description 47
- 238000000034 method Methods 0.000 claims description 38
- 239000000835 fiber Substances 0.000 claims description 37
- 239000011148 porous material Substances 0.000 claims description 20
- 230000002745 absorbent Effects 0.000 claims description 14
- 239000002250 absorbent Substances 0.000 claims description 14
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 12
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 12
- 229920002334 Spandex Polymers 0.000 claims description 9
- -1 polyethylene terephthalate Polymers 0.000 claims description 9
- 239000004759 spandex Substances 0.000 claims description 9
- 239000000853 adhesive Substances 0.000 claims description 8
- 230000001070 adhesive effect Effects 0.000 claims description 8
- 229920000058 polyacrylate Polymers 0.000 claims description 8
- 239000011324 bead Substances 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 7
- 239000013013 elastic material Substances 0.000 claims description 6
- 239000004743 Polypropylene Substances 0.000 claims description 5
- 229920001155 polypropylene Polymers 0.000 claims description 5
- 229920001778 nylon Polymers 0.000 claims description 4
- 239000004677 Nylon Substances 0.000 claims description 3
- 125000000129 anionic group Chemical group 0.000 claims description 3
- 239000012982 microporous membrane Substances 0.000 claims description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 claims 2
- 239000005020 polyethylene terephthalate Substances 0.000 claims 2
- 208000027418 Wounds and injury Diseases 0.000 description 84
- 206010052428 Wound Diseases 0.000 description 64
- 239000002874 hemostatic agent Substances 0.000 description 43
- 208000032843 Hemorrhage Diseases 0.000 description 30
- 238000010521 absorption reaction Methods 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 230000000740 bleeding effect Effects 0.000 description 25
- 208000014674 injury Diseases 0.000 description 22
- 230000006378 damage Effects 0.000 description 21
- 238000012360 testing method Methods 0.000 description 20
- 229920000247 superabsorbent polymer Polymers 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- 239000000499 gel Substances 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 11
- 241000282898 Sus scrofa Species 0.000 description 11
- 230000004083 survival effect Effects 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 238000007789 sealing Methods 0.000 description 9
- 210000004013 groin Anatomy 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 206010053567 Coagulopathies Diseases 0.000 description 7
- 230000035602 clotting Effects 0.000 description 7
- 230000015271 coagulation Effects 0.000 description 7
- 238000005345 coagulation Methods 0.000 description 7
- 229910001415 sodium ion Inorganic materials 0.000 description 7
- 230000004872 arterial blood pressure Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 230000006835 compression Effects 0.000 description 6
- 238000007906 compression Methods 0.000 description 6
- 230000034994 death Effects 0.000 description 6
- 231100000517 death Toxicity 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000002203 pretreatment Methods 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 239000002861 polymer material Substances 0.000 description 5
- 239000004583 superabsorbent polymers (SAPs) Substances 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 210000001105 femoral artery Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 231100000518 lethal Toxicity 0.000 description 4
- 230000001665 lethal effect Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229920002959 polymer blend Polymers 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000002028 premature Effects 0.000 description 4
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 4
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000005060 rubber Substances 0.000 description 3
- 230000000472 traumatic effect Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- 229940030225 antihemorrhagics Drugs 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000012765 fibrous filler Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000002637 fluid replacement therapy Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- GASMGDMKGYYAHY-UHFFFAOYSA-N 2-methylidenehexanamide Chemical class CCCCC(=C)C(N)=O GASMGDMKGYYAHY-UHFFFAOYSA-N 0.000 description 1
- QPMZMJZDPOJMLC-UHFFFAOYSA-N 3-methyl-2-methylidenebutanamide Chemical class CC(C)C(=C)C(N)=O QPMZMJZDPOJMLC-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 101100313164 Caenorhabditis elegans sea-1 gene Proteins 0.000 description 1
- 206010015719 Exsanguination Diseases 0.000 description 1
- 208000009087 False Aneurysm Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010048975 Vascular pseudoaneurysm Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- GPUADMRJQVPIAS-QCVDVZFFSA-M cerivastatin sodium Chemical compound [Na+].COCC1=C(C(C)C)N=C(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 GPUADMRJQVPIAS-QCVDVZFFSA-M 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000002586 coronary angiography Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002350 laparotomy Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 238000005029 sieve analysis Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01008—Non-adhesive bandages or dressings characterised by the material
- A61F13/01017—Non-adhesive bandages or dressings characterised by the material synthetic, e.g. polymer based
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01021—Non-adhesive bandages or dressings characterised by the structure of the dressing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01034—Non-adhesive bandages or dressings characterised by a property
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01034—Non-adhesive bandages or dressings characterised by a property
- A61F13/01038—Flexibility, stretchability or elasticity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00463—Plasters use haemostatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00463—Plasters use haemostatic
- A61F2013/00472—Plasters use haemostatic with chemical means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/0054—Plasters use for deep wounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00655—Plasters adhesive
- A61F2013/00659—Plasters adhesive polymeric base
- A61F2013/00663—Plasters adhesive polymeric base acrylic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00655—Plasters adhesive
- A61F2013/00685—Plasters adhesive soluble in liquid, e.g. of particular pH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83739906P | 2006-08-11 | 2006-08-11 | |
| US60/837,399 | 2006-08-11 | ||
| PCT/US2007/017753 WO2008021212A2 (en) | 2006-08-11 | 2007-08-10 | High speed swelling, pressure exerting hemostatic device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2695526A1 true CA2695526A1 (en) | 2008-02-21 |
Family
ID=38667143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2695526A Abandoned CA2695526A1 (en) | 2006-08-11 | 2007-08-10 | High speed swelling, pressure exerting hemostatic device |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7838716B2 (enExample) |
| EP (1) | EP2063920A2 (enExample) |
| JP (1) | JP2010500116A (enExample) |
| AU (1) | AU2007284665A1 (enExample) |
| CA (1) | CA2695526A1 (enExample) |
| WO (1) | WO2008021212A2 (enExample) |
| ZA (1) | ZA200901707B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
| GB0325129D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus in situ |
| US10058642B2 (en) | 2004-04-05 | 2018-08-28 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
| CN101883546B (zh) | 2007-11-21 | 2017-05-10 | 史密夫及内修公开有限公司 | 伤口包敷物 |
| GB0722820D0 (en) | 2007-11-21 | 2008-01-02 | Smith & Nephew | Vacuum assisted wound dressing |
| EP3354243A1 (en) | 2007-11-21 | 2018-08-01 | Smith & Nephew PLC | Wound dressing |
| US8828358B2 (en) * | 2008-03-11 | 2014-09-09 | Materials Modifications, Inc. | In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide |
| US8852558B2 (en) * | 2008-03-11 | 2014-10-07 | Materials Modification, Inc. | In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst |
| RU2471461C2 (ru) | 2008-05-30 | 2013-01-10 | КейСиАй ЛАЙСЕНЗИНГ, ИНК. | Закрывающие подушки и системы пониженного давления для линейных ран |
| EP2279018B8 (en) | 2008-05-30 | 2017-04-19 | KCI Licensing, Inc. | Reduced-pressure, compression systems and apparatuses for use on a curved body part |
| GB2468905B (en) * | 2009-03-27 | 2013-12-11 | Brightwake Ltd | Wound packing material |
| US20100280428A1 (en) * | 2009-04-25 | 2010-11-04 | Widgerow Alan D | Medical device for shrinking open wounds |
| JP2012525930A (ja) * | 2009-05-04 | 2012-10-25 | オレゴン・バイオメディカル・エンジニアリング・インスティテュート・インコーポレイテッド | 出血コントロール機器および方法 |
| BR112012008087A2 (pt) * | 2009-08-05 | 2016-03-01 | Tyco Healthcare | curativo de ferimento cirúrgico incorporando esferas de hidrogel conectadas tendo um eletrodo embutido naquele lugar |
| GB0922258D0 (en) * | 2009-12-21 | 2010-02-03 | Smith & Nephew | Device for administration to a wound cavity |
| US20110237994A1 (en) * | 2010-03-25 | 2011-09-29 | Combat Medical Systems, Llc | Void-filling wound dressing |
| US9061095B2 (en) | 2010-04-27 | 2015-06-23 | Smith & Nephew Plc | Wound dressing and method of use |
| US9623223B2 (en) | 2011-02-16 | 2017-04-18 | Revmedx, Inc. | Wound dressings comprising a plurality of liquid-expandable articles |
| US20120209232A1 (en) * | 2011-02-16 | 2012-08-16 | Andrew Barofsky | Wound stasis dressing for large surface wounds |
| EP2741788A4 (en) | 2011-08-14 | 2015-03-25 | Materials Modification Inc | METHOD AND COMPOSITION FOR IN-SITU FORMATION OF AN ARTIFICIAL BARRIER FOR FIGHTING BLOOD LOSS |
| US8993831B2 (en) * | 2011-11-01 | 2015-03-31 | Arsenal Medical, Inc. | Foam and delivery system for treatment of postpartum hemorrhage |
| US20160175157A1 (en) * | 2014-12-22 | 2016-06-23 | Terence W. Kolb | Impregnable and Expanding Wound Packing Article |
| EP3248578A1 (en) * | 2016-05-24 | 2017-11-29 | Biocer-Entwicklungs-GmbH | Unit for hemostasis and arrangement containing the same |
| CN107252335B (zh) * | 2017-06-28 | 2023-02-28 | 王洛 | 止血装置及用于推送该止血装置的注射器 |
| EP3672539B1 (en) * | 2017-08-24 | 2025-05-07 | Arctic Express Packs LLC | Cold packs system |
| GB202310268D0 (en) * | 2023-07-05 | 2023-08-16 | Smith & Nephew | Negative pressure wound therapy devices and methods utilizing a wound filler |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4293609A (en) * | 1979-07-09 | 1981-10-06 | The Dow Chemical Company | Flexible absorbent laminates |
| DE3464326D1 (en) * | 1983-04-06 | 1987-07-30 | Smith & Nephew Ass | Dressing |
| US4957795A (en) * | 1988-05-13 | 1990-09-18 | Minnesota Mining And Manufacturing Company | Absorbent elastomeric wound dressing |
| IL92966A (en) * | 1989-01-12 | 1995-07-31 | Pfizer | Dispensing devices powered by hydrogel |
| US5824004A (en) * | 1990-06-18 | 1998-10-20 | The Procter & Gamble Company | Stretchable absorbent articles |
| DE4021353A1 (de) * | 1990-07-05 | 1992-01-09 | Rotecno Ag | Medizinisches operations-abdecktuch |
| US5998032A (en) * | 1992-08-17 | 1999-12-07 | Weyerhaeuser Company | Method and compositions for enhancing blood absorbence by superabsorbent materials |
| GB2272645B8 (en) * | 1992-11-23 | 2010-02-10 | Johnson & Johnson Medical | Wound dressing |
| GB2324732B (en) * | 1997-05-02 | 2001-09-26 | Johnson & Johnson Medical | Absorbent wound dressings |
| US6660301B1 (en) * | 1998-03-06 | 2003-12-09 | Biosphere Medical, Inc. | Injectable microspheres for dermal augmentation and tissue bulking |
| US20070009586A1 (en) | 2000-02-29 | 2007-01-11 | Cohen Kelman I | Wound dressings containing complexes of transition metals and alginate for elastase sequestering |
| US6627785B1 (en) | 2000-02-29 | 2003-09-30 | Virginia Commwealth University | Wound dressings with protease-lowering activity |
| US20040013715A1 (en) * | 2001-09-12 | 2004-01-22 | Gary Wnek | Treatment for high pressure bleeding |
| CN1455659A (zh) | 2000-09-12 | 2003-11-12 | 弗吉尼亚州立大学 | 高压出血的治疗 |
| DE60235087D1 (de) * | 2001-05-22 | 2010-03-04 | Uni Charm Corp | Interlabial-polster |
| US8741335B2 (en) * | 2002-06-14 | 2014-06-03 | Hemcon Medical Technologies, Inc. | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan |
| US7279177B2 (en) * | 2002-06-28 | 2007-10-09 | Ethicon, Inc. | Hemostatic wound dressings and methods of making same |
| US7495146B2 (en) * | 2004-07-15 | 2009-02-24 | Vivo Ltd. Partnership | Wound dressing |
| US11167058B2 (en) | 2005-02-15 | 2021-11-09 | Virginia Commonwealth University | Hemostasis of wound having high pressure blood flow |
-
2007
- 2007-08-10 AU AU2007284665A patent/AU2007284665A1/en not_active Abandoned
- 2007-08-10 ZA ZA200901707A patent/ZA200901707B/xx unknown
- 2007-08-10 CA CA2695526A patent/CA2695526A1/en not_active Abandoned
- 2007-08-10 WO PCT/US2007/017753 patent/WO2008021212A2/en not_active Ceased
- 2007-08-10 JP JP2009523851A patent/JP2010500116A/ja not_active Withdrawn
- 2007-08-10 US US11/891,660 patent/US7838716B2/en not_active Expired - Fee Related
- 2007-08-10 EP EP07811231A patent/EP2063920A2/en not_active Withdrawn
-
2010
- 2010-11-22 US US12/952,037 patent/US8395010B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2063920A2 (en) | 2009-06-03 |
| AU2007284665A1 (en) | 2008-02-21 |
| US20080071207A1 (en) | 2008-03-20 |
| US7838716B2 (en) | 2010-11-23 |
| US8395010B2 (en) | 2013-03-12 |
| ZA200901707B (en) | 2010-06-30 |
| US20110270300A1 (en) | 2011-11-03 |
| WO2008021212A2 (en) | 2008-02-21 |
| JP2010500116A (ja) | 2010-01-07 |
| WO2008021212A3 (en) | 2008-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8395010B2 (en) | High speed swelling, pressure exerting hemostatic device | |
| JP7438264B2 (ja) | 創傷被覆材 | |
| RU2497490C2 (ru) | Заживляющая раневая повязка, снижающая температуру | |
| JP5955995B2 (ja) | 止血材 | |
| KR101148248B1 (ko) | 생명을 위협하는 심한 출혈을 억제하기 위한 상처용 드레싱및 방법 | |
| KR100953466B1 (ko) | 생명을 위협하는 심각한 출혈에 사용되는 상처 드레싱 제조방법 | |
| EP0108063B1 (en) | Absorbent body with semipermeable membrane | |
| AU2002312493A1 (en) | Wound dressing and method for controlling severe, life-threatening bleeding | |
| KR20070033948A (ko) | 생명을 위협하는 심한 출혈을 억제하기 위한 상처용 드레싱및 방법 | |
| WO2010102283A2 (en) | Hemostatic agent composition, delivery system and method | |
| JP2007516051A (ja) | キトサンのような親水性ポリマースポンジ構造体から形成される、組織被覆用のアセンブリ、システムおよび方法 | |
| US20170128270A1 (en) | Wound dressing | |
| Abdullazhanov et al. | NEW COMPOSITE HEMOSTATIC SYSTEM MEMBRANE IN LIVER SURGERY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |
Effective date: 20140812 |